Page URL:

Faulty X chromosome gene linked to dementia

19 January 2009
Appeared in BioNews 491

A team from the Mayo Clinic College of Medicine in Jacksonville, Florida, US, has discovered a new gene variant that seems to increase the risk of developing Alzheimer's disease. The discovery is the first evidence of gender-specific risk factor for the disease because the variant is on the X chromosome, of which females have two copies, but men have only one. The results were published online in the journal Nature Genetics, and may partly explain why more women than men tend to develop the disease.

Alzheimer's disease is a progressive neurodegenerative disorder, characterised by personality changes and loss of memory, which eventually leads to death. The most common form, known as 'Late-onset Alzheimer's disease' (LOAD), affects approximately 700,000 people in the UK.

The Mayo team carried out a two-stage study involving detailed genetic analyses of nearly 5000 people, who were either Alzheimer's patients or unaffected control subjects. The study identified a suspect 'single letter' change in the genetic code of the gene PCDH11X that was significantly correlated with susceptibility to LOAD. The gene PCDH11X controls production of a protein called a protocadherin, part of a family of molecules that promote cell adhesion and signalling in the central nervous system.

When compared to non-carriers, the raised risk of Alzheimer's in people with the PCDH11X variant was relatively small in men (18 per cent increased risk) and women with just one copy of the rogue gene variant (26 per cent increased risk). The effect was most pronounced in women who carried two copies - one inherited from each parent - who have a 75 per cent increased risk over female non-carriers. To put this in context, a mutation in the well-known and previously studied APOE 4 gene was judged to increase risk in the Mayo group subjects by 380 percent if they carried one copy and 1050 per cent if they carried two copies.

'Although the presence of the mutation offers strong evidence of a heightened risk, further research needs to be done to determine how big of a risk', said Dr Steven Younkin, the George M. Eisenberg professor of neuroscience at the Mayo Clinic. He added: 'It is important to analyse many additional Alzheimer's disease cases and controls before drawing any final conclusions about the strength of the association and the degree of risk it confers on developing Alzheimer's disease'.

Gender insight in Alzheimer's study
The Press Association |  11 January 2009
Gene Variant May Hike Women's Risk of Alzheimer's
The Washington Post |  12 January 2009
Variants In Gene On X Chromosome Associated With Increased Susceptibility To Alzheimer's
ScienceDaily |  13 January 2009
Women-only gene link to dementia
BBC News Online |  12 January 2009
15 December 2014 - by Dr Rachel Montgomery 
Men with poor semen quality are more likely to also suffer from unrelated health problems, such as hypertension, a study suggests...
18 January 2010 - by Alison Cranage 
American scientists have found that a genetic variation could be associated with slower memory decline and a lower risk of Alzheimer's disease and dementia. The preliminary findings shed light on processes in the brain that could contribute to memory loss and dementia. The work was published in the Journal of the American Medical Association last week....
16 March 2009 - by Ailsa Stevens 
A gene mutation linked to the accumulation of the peptide beta-amyloid in the brain - thought to cause Alzheimer's - has been shown to trigger the disease when individuals carry two copies and help protect against the disease when they carry only one, according to a study published in...
3 November 2008 - by Ailsa Stevens 
A study examining the genomes of more than 1,300 families has revealed four new genes potentially linked to the most common late-onset form of Alzheimer's disease, according to a study published in the American Journal of Human Genetics last week. The researchers, based at the Massachusetts General...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.